Connor, Clark & Lunn Investment Management Ltd. Mannkind Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Mannkind Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 1,901,780 shares of MNKD stock, worth $10.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,901,780
Previous 1,885,370
0.87%
Holding current value
$10.6 Million
Previous $11.8 Million
3.28%
% of portfolio
0.06%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding MNKD
# of Institutions
255Shares Held
150MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$89.8 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$53.6 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$51.2 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$48.9 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.44B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...